Point72 Asset Management’s Biogen BIIB Stock Holding History

Point72 Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$862K	Sell	4,700 -996,800	-100%	-$184M	﹤0.01%	2852
2025 Q4	$176M	Buy	1,001,500 +1,500	+0.2%	+$245K	0.2%	72
2025 Q3	$140M	Buy	1,000,000 +750,000	+300%	+$101M	0.23%	76
2025 Q2	$31.4M	Buy	+250,000	New	+$31.2M	0.06%	353
2022 Q1	–	Sell	-10,000	Closed	-$2.4M	–	1178
2021 Q4	$2.4M	Buy	+10,000	New	+$2.57M	0.01%	793
2020 Q2	–	Sell	-69,600	Closed	-$22M	–	812
2020 Q1	$22M	Buy	+69,600	New	+$21.1M	0.18%	163

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Asset Management's BIIB Position: Q1 2026 in Review

Point72 Asset Management reduced its Biogen (BIIB) stake by 71% in Q1 2026, selling an estimated $369M and leaving 809,617 shares worth $148M. The position accounts for 0.19% of the portfolio, ranked #97.

Point72 Asset Management first reported a position in BIIB in Q2 2014 and has held it in 34 quarters since. The position peaked at $543M in Q3 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Point72 Asset Management held 809,617 shares of Biogen worth $148M as of Q1 2026.
Point72 Asset Management sold 2,003,575 Biogen shares in Q1 2026, an estimated $369M.
Biogen made up 0.19% of Point72 Asset Management's portfolio in Q1 2026, its #97 holding.
Point72 Asset Management first reported a position in Biogen in Q2 2014 and has held it in 34 quarters since.
Point72 Asset Management's Biogen position peaked at $543M in Q3 2025.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.